Sarafotoxin 6c (S6c) reduces infarct size and preserves mRNA for the ETB receptor in the ischemic/reperfused myocardium of anesthetized rats

Journal of Cardiovascular Pharmacology

Volumn 44, Issue 2, 2004, Pages 148-154

  Crockett, Thomas R ^a   Gray, Gillian A ^b   Kane, Kathleen A ^a   Wainwright, Cherry L ^a,c  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c ROBERT GORDON UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; ENDOTHELIN B RECEPTOR AGONIST; ENDOTHELIN RECEPTOR; EVANS BLUE; HYPNORM; MESSENGER RNA; MIDAZOLAM; SARAFOTOXIN S6C; TRIPHENYLTETRAZOLIUM;

ANESTHESIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DOSE TIME EFFECT RELATION; DRUG RECEPTOR BINDING; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE REPERFUSION; ISCHEMIC HEART DISEASE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN MODIFICATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; TISSUE SLICE;

ANIMALS; BLOOD PRESSURE; CORONARY DISEASE; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; EVANS BLUE; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; INJECTIONS, INTRAVENOUS; LIGATION; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TETRAZOLIUM SALTS; TIME FACTORS; VENTRICULAR FIBRILLATION; VIPER VENOMS;

EID: 3242790924     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200408000-00002     Document Type: Article

References (35)

1. Ray SG, McMurray JJ, Morton JJ, et al. Circulating endothelin is not extracted by the pulmonary circulation in man. Chest. 1992;102:1143-1144.
2. Liu J, Chen R, Casley DJ, et al. Ischaemia and reperfusion increase 1251 labelled endothelin-1 binding in rat cardiac membranes. Am J Physiol. 1990;258:H829-H835.
3. Sargent CA, Liu EC, Chao CC, et al. Role of endothelin receptor subtype B (ET-B) in myocardial ischaemia. Life Sci. 1994;55:1833-1844.
4. Grover GJ, Dzwoncyzk S, Parham CS. The endothelin-1 receptor antagonist BQ-123 reduces infarct size in a canine model of coronary occlusion and reperfusion. Cardiovasc Res. 1993;27:1613-1618.
5. Kojima M, Kusumoto K, Fujiwara S, et al. Role of endogenous endothelin in the extension of myocardial infarct size, studied with the endothelin receptor antagonist, TAK-055. J Cardiovasc Pharmacol. 1995;26(Suppl 3):S365-S368.
6. Wang QD, Li XS, Lundberg JM, et al. Protective effects of non-peptide endothelin receptor antagonist bosentan on myocardial ischaemia and reperfusion injury in the pig. Cardiovasc Res. 1995;29:805-812.
7. A receptor antagonist, BQ-123, on ischaemic arrhythmias in anaesthetized rats. J Cardiovasc Pharmacol. 1995;25:634-642.
8. Sharif I, Kane KA, Wainwright CL. Endothelin and ischaemic arrhythmias-anti-arrhythmic or arrhythmogenic? Cardiovasc Res. 1998;39:625-632.
9. D'Orléans-Juste PD, Labonté J, Bkaily G, et al. Function of the endothelin B receptor in cardiovascular physiology and pathophysiology. Pharmacol Ther. 2002;95:221-238.
10. Hide EJ, Piper J, Thiemermann C. Endothelin-1-induced reduction of myocardial infarct size by activation of ATP-sensitive potassium channels in a rabbit model of myocardial ischaemia and reperfusion. Br J Pharmacol. 1995;116:2597-2602.
11. ATP channels in the isolated rat heart. Cardiovasc Res. 1996;32:920-929.
12. Wang P, Gallagher KP, Downey JM, et al. Pretreatment with endothelin-1 mimics ischemic preconditioning against infarction in isolated rabbit heart. J Mol Cell Cardiol. 1996;28:579-588.
13. Crockett TR, Sharif I, Kane KA, et al. Sarafotoxin-6c protects against ischaemia-induced cardiac arrhythmias in vivo and in vitro in the rat. J Cardiovasc Pharmacol. 2000;36(Suppl 1):S297-S299.
14. Pönicke K, Volgelsang M, Heinroth M, et al. Endothelin receptors in the failing and non-failing human heart. Circulation. 1998;97:744-751.
15. Pieske B, Beyermann B, Breu V, et al. Functional effects of endothelin and regulation of endothelin receptors in isolated human nonfailing and failing myocardium. Circulation. 1999;99:1802-1809.
16. Zolk O, Quattek J, Sitzler G, et al. Expression of endothelin-1, endothelin-converting enzyme and endothelin receptors in chronic heart failure. Circulation. 1999;99:2118-2123.
17. Gan XT, Chakrabarti S, Karmazyn M. Increased endothelin-1 and endothelin receptor expression in myocytes of ischaemic and reperfused rat hearts and ventricular myocytes exposed to ischaemic conditions and its inhibition by nitric oxide generation. Can J Physiol Pharmacol. 2003;82:105-113.
18. Roubert P, Viossat I, Lonchampt MO, et al. Endothelin receptor regulation by endothelin synthesis in vascular smooth muscle cells: effects of dexamethasone and phosphoramidon. J Vasc Res. 1993;30:139-144.
19. Clark C, Foreman MI, Kane KA, et al. Coronary artery ligation in rats as a method for the production of experimental arrhythmias and for the determination of infarct size. J Pharmacol Meth. 1980;3:357-368.
20. Bullock GR, Lepran I, Parratt JR, et al. Effects of a combination of metoprolol and dazmegrel on myocardial infarct size in rats. Br J Pharmacol. 1984;86:235-240.
21. B receptor mRNA by competitive reverse transcription-polymerase chain reaction: development of a multispecies assay. Anal Biochem. 1999;271:93-96.
22. Parratt JR, Kane KA. K-ATP channels in ischemic preconditioning. Cardiovasc Res. 1994;28:783-787.
23. + channels via pertussis-toxin-sensitive G-proteins. Cardiovasc Res. 1997;33:123-130.
24. Chiariello M, Golino P, Cappelli-Bigazzi M, et al. Reduction in infarct size by the prostacyclin analogue iloprost (ZK 36374) after experimental coronary artery occlusion-reperfusion. Am Heart J. 1988;115:499-504.
25. Lefer AM, Siegfried MR, Ma X-L. Protection of ischemia-reperfusion injury by sydnonimine donors via inhibition of neutrophil-endothelium interaction. J Cardiovasc Pharmacol. 1993;22(Suppl 7):S27-S33.
26. Crockett TR, McBride M, Ness KF, et al. The effect of S6c on platelet aggregation and leukocyte free radical generation in rat blood in vitro and ex vivo. Br J Pharmacol. 2000;131:162P.
27. Altug S, Demiryürek AT, Cakiçi I, et al. The beneficial effects of peroxynitrite on ischaemia-reperfusion arrhythmias in isolated rat hearts. Eur J Pharmacol. 1999;384:157-162.
28. Altug S, Demiryürek AT, Kane KA, et al. Evidence for the involvement of peroxynitrite in ischaemic preconditioning in rat isolated hearts. Br J Pharmacol. 2000;130:125-131.
29. Lefer DJ, Scalia R, Campbell B, et al. Peroxynitrite inhibits leukocyte-endothelial cell interactions and protects against ischemia-reperfusion injury in rats. J Clin Invest. 1997;99:684-691.
30. Saito I, Itoh H, Chun T, et al. Oxidative stress suppresses the endothelial secretion of endothelin. J Cardiovasc Pharmacol. 1998;31:S345-S347.
31. B receptors in rat. Stroke. 2002;33:2311-2316.
32. Tsuji S, Sawamura A, Watanabe H, et al. Plasma endothelin levels during ischemia and reperfusion. Life Sci. 1991;48:1745-1749.
33. B receptor mRNA: Participation of cAMP. J Cardiovasc Pharmacol. 1995;26(Suppl 3):S272-S275.
34. Oksche A, Boese G, Horstmeyer A, et al. Late endosomal/lysosomal targeting and lack of recycling of the ligand-occupied endothelin B receptor. Mol Pharmacol. 2000;57:1104-1113.
35. Kanno K, Hirata Y, Tsujino M, et al. Up-regulation of ETB receptor subtype mRNA by angiotensin II in rat cardiomyocytes. Biochem Biophys Res Commun. 1993;194:1282-1287.